754 related articles for article (PubMed ID: 1233863)
1. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
Lebacq E; David L
Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
[No Abstract] [Full Text] [Related]
3. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
László FA; Czakó L
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
[No Abstract] [Full Text] [Related]
5. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
Limal JM; Mugner E; Czernichow P
Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
[TBL] [Abstract][Full Text] [Related]
6. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
7. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
Radó JP; Marosi J; Borbély L; Takó J
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
Czakó L; László F; Manning M
Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
[No Abstract] [Full Text] [Related]
9. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
10. Anitdiuretic effect of carbamazepine in diabetes insipidus.
Czakó L; László FA
Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):58-64. PubMed ID: 1150363
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diabetes insipidus with DDAVP.
Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
[TBL] [Abstract][Full Text] [Related]
12. Transient vasopressin-resistant diabetes insipidus of pregnancy.
Ford SM
Obstet Gynecol; 1986 Aug; 68(2):288-9. PubMed ID: 3737046
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
14. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
15. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
16. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
Radó JP; Marosi J; Fischer J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
[TBL] [Abstract][Full Text] [Related]
17. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
Radó JP; Marosi J
Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
[TBL] [Abstract][Full Text] [Related]
18. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Laczi F; Mezei G; Julesz J; Lázló FA
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of post-craniotomy diabetes insipidus with 1-desamino-8-D-arginine vasopressin].
Parra-Paredes MS; Blanco-López A; Dorantes-Alvarez LM
Bol Med Hosp Infant Mex; 1988 Jun; 45(6):378-80. PubMed ID: 3166684
[No Abstract] [Full Text] [Related]
20. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
Bernasconi S; Vanelli M; Giovannelli G
Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
